Atlas Trials

Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma

Clinical trial NCT01449942 · COMPLETED

Trial details

NCT number
NCT01449942
Sponsor
Xiangya Hospital of Central South University
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Nasopharyngeal Carcinoma
Start date
2009-05-01
Primary completion
2011-04-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.